RVNC
Price:
$3.65
Market Cap:
$381.02M
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing D...[Read more]
Industry
Biotechnology
IPO Date
2014-02-06
Stock Exchange
NASDAQ
Ticker
RVNC
According to Revance Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Revance Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RVNC's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Revance Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
| 2014 | 0% | 0% |
The current Dividend Yield of Revance Therapeutics, Inc. (RVNC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Revance Therapeutics, Inc.’s Dividend Yield is less than Orchard Therapeutics plc (0%), less than G1 Therapeutics, Inc. (0%), less than Vigil Neuroscience, Inc. (0%), less than Checkpoint Therapeutics, Inc. (0%), less than Y-mAbs Therapeutics, Inc. (0%), less than Climb Bio, Inc. (0%), less than iTeos Therapeutics, Inc. (0%), less than Claritev Corporation (0%), less than Big Cypress Acquisition Corp. (0%), less than SomaLogic, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $380.11M | |
| 0% | $377.75M | |
| 0% | $375.71M | |
| 0% | $367.72M | |
| 0% | $391.22M | |
| 0% | $118.30M | |
| 0% | $448.68M | |
| 0% | $589.22M | |
| 0% | $425.36M | |
| 0% | $396.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revance Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Revance Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Revance Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Revance Therapeutics, Inc. (RVNC)?
What is the highest Dividend Yield for Revance Therapeutics, Inc. (RVNC)?
What is the 3-year average Dividend Yield for Revance Therapeutics, Inc. (RVNC)?
What is the 5-year average Dividend Yield for Revance Therapeutics, Inc. (RVNC)?
How does the current Dividend Yield for Revance Therapeutics, Inc. (RVNC) compare to its historical average?